Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Examination of CK2a and NF-?B p65 expression in human benign prostatic hyperplasia and prostate cancer tissues.

Qaiser F, Trembley JH, Sadiq S, Muhammad I, Younis R, Hashmi SN, Murtaza B, Rector TS, Naveed AK, Ahmed K. Examination of CK2a and NF-?B p65 expression in human benign prostatic hyperplasia and prostate cancer tissues. Molecular and Cellular Biochemistry. 2016 Sep 1; 420(1-2):43-51.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions


Protein kinase CK2 plays a critical role in cell growth, proliferation, and suppression of cell death. CK2 is overexpressed, especially in the nuclear compartment, in the majority of cancers, including prostate cancer (PCa). CK2-mediated activation of transcription factor nuclear factor kappa B (NF-?B) p65 is a key step in cellular proliferation, resulting in translocation of NF-?B p65 from the cytoplasm to the nucleus. As CK2 expression and activity are also elevated in benign prostatic hyperplasia (BPH), we sought to increase the knowledge of CK2 function in benign and malignant prostate by examination of the relationships between nuclear CK2 and nuclear NF-?B p65 protein expression. The expression level and localization of CK2a and NF-?B p65 proteins in PCa and BPH tissue specimens was determined. Nuclear CK2a and NF-?B p65 protein levels are significantly higher in PCa compared with BPH, and these proteins are positively correlated with each other in both diseases. Nuclear NF-?B p65 levels correlated with Ki-67 or with cytoplasmic NF-?B p65 expression in BPH, but not in PCa. The findings provide information that combined analysis of CK2a and NF-?B p65 expression in prostate specimens relates to the disease status. Increased nuclear NF-?B p65 expression levels in PCa specifically related to nuclear CK2a levels, indicating a possible CK2-dependent relationship in malignancy. In contrast, nuclear NF-?B p65 protein levels related to both Ki-67 and cytoplasmic NF-?B p65 levels exclusively in BPH, suggesting a potential separate impact for NF-?B p65 function in proliferation for benign disease as opposed to malignant disease.

Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.